Atrial Fibrillation Trial, Recruiting NCT06589700 Sponsor: Luciano A. Sposato Condition: Atrial Fibrillation
Back to Atrial Fibrillation

Atrial Fibrillation Trial, Recruiting

NCT06589700
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults who have had an acute ischemic stroke (a stroke caused by a blood clot) affecting any part of the brain, whether or not the cause is known
  • People who have a type of irregular heart rhythm called paroxysmal atrial fibrillation (AF), meaning it comes and goes rather than being constant — this includes AF that was already known before the stroke, AF picked up on a heart tracing (ECG) taken at the hospital, or AF detected during a 14-day heart monitor worn after the stroke

Who may not be able to join:

  • People who do not wish to give their consent to take part
  • People who have AF that is permanent or long-lasting (rather than the kind that comes and goes)
  • People who have an allergy to iodinated contrast agents (a type of dye sometimes used in medical scans)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Luciano A Sposato, MD, Western University

Phone: 519-685-8500

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Luciano A. Sposato
Registry
ClinicalTrials.gov
Start date
16 October 2025
Est. completion
1 October 2027

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Progression of AF burden; Total AF burden

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov